Q Can you provide a formulation for compounding meloxicam oral suspension?
A Meloxicam oral suspension recently was released as a commercially available product. It should not be extemporaneously compounded unless the manufacturer has discontinued the product, the pharmacist cannot obtain it, or a patient medical need is present (eg, documented allergy, specific base or salt requirements, etc). Officially, the use of a compounded product to replace a commercially manufactured product is "allowed" where the compounding is not in violation of FDA Compliance Policy Guide Sec. 460.200, Pharmacy Compounding.
Label: "Shake Well,""Keep in Refrigerator." Stability: No information found. Use USP Compounding Monograph <795> information: 14 days beyond-use dating, refrigerated.
No claims are made as to the uses, safety, efficacy, or bioavailability of this product. The formula is for informational purposes only.
E-mail your compounding questions to firstname.lastname@example.org
Mr. Erickson is director of professional affairs at Gallipot Inc.
Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc.
Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today?
Clinical features with downloadable PDFs